The trouble with spectroscopy papers

Writing a critique and guide for authors of clinical spectroscopy research papers is a likely way of ensuring that one never sees another of one's own papers published in this field. Nevertheless, it is disappointing, though perhaps predictable, that despite its historical foundations in quantitative spectroscopy, the field has its fair share of findings that are not so obviously reconciled. Here is the view of one author, one referee, and one spectroscopy protagonist about what might be expected of a clinical spectroscopy paper. In addition to novelty, the fundamental criteria for acceptance should be that the conclusions are supported by properly and objectively quantified results, and that sufficient experimental detail is provided so that one skilled in the art could reproduce the study and its findings.

[1]  W. Shuman The poor quality of early evaluations of MR imaging: a reply. , 1988, AJR. American journal of roentgenology.

[2]  G A Holland,et al.  A simple method for processing NMR spectra in which acquisition is delayed: Applications to in vivo localized 31P NMR spectra acquired using the DRESS technique , 1988, Magnetic resonance in medicine.

[3]  Hart,et al.  Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 Tesla. , 1984, Radiology.

[4]  R. Shulman,et al.  Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P A Bottomley,et al.  Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? , 1989, Radiology.

[6]  M McCally,et al.  The poor quality of early evaluations of magnetic resonance imaging. , 1988, JAMA.

[7]  G. Radda,et al.  Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G K Radda,et al.  Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance. , 1981, The New England journal of medicine.

[9]  P R Luyten,et al.  Broadband proton decoupling in human 31p NMR spectroscopy , 1989, NMR in biomedicine.

[10]  M. Weiner,et al.  In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease. , 1990, The American journal of cardiology.

[11]  C. Hardy,et al.  Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance. , 1989, Clinical chemistry.

[12]  C. Hardy,et al.  Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. , 1991, American heart journal.

[13]  J. M. Carr,et al.  Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. , 1986, The New England journal of medicine.

[14]  Christopher J. Hardy,et al.  PROGRESS in efficient three-dimensional spatially localized in vivo31P NMR spectroscopy using multidimensional spatially selective (ϱ) pulses , 1987 .

[15]  J. D. de Certaines,et al.  Lipoproteins in heart transplantation: Proton magnetic resonance spectroscopy of plasma , 1991, Magnetic resonance in medicine.

[16]  C J Hardy,et al.  Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants. , 1991, Radiology.

[17]  J. Frahm,et al.  Localized 31P NMR spectroscopy of the amt human brain in vivo using stimulated-echo (STEAM) sequences , 1990 .

[18]  D. Collins,et al.  A quantitative analysis of the accuracy of In Vivo pH measurements with 31P NMR spectroscopy: Assessment of pH measurement methodology , 1991, NMR in biomedicine.

[19]  P R Luyten,et al.  Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. , 1990, Radiology.

[20]  O. Klepp,et al.  Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer. , 1990, The New England journal of medicine.

[21]  D. Menon,et al.  Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. , 1990, Journal of computer assisted tomography.

[22]  C J Hardy,et al.  Problems and expediencies in human 31P spectroscopy. The definition of localized volumes, dealing with saturation and the technique‐dependence of quantification , 1989, NMR in biomedicine.

[23]  G B Matson,et al.  P-31 MR spectroscopy of normal human brain and brain tumors. , 1990, Radiology.

[24]  G. Radda,et al.  The study of human organs by phosphorus-31 topical magnetic resonance spectroscopy. , 1987, The British journal of radiology.

[25]  C. Hardy,et al.  Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. , 1990, The New England journal of medicine.

[26]  Truman R. Brown,et al.  The accuracy of quantification from 1D NMR spectra using the PIQABLE algorithm , 1989 .

[27]  P. Luyten,et al.  Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge , 1988, Magnetic resonance in medicine.

[28]  P R Luyten,et al.  Experimental approaches to image localized human 31P NMR spectroscopy , 1989, Magnetic resonance in medicine.

[29]  J. Vion-Dury,et al.  NMR spectroscopy of plasma during acute rejection of transplanted hearts , 1991, The Lancet.

[30]  Albert Macovski,et al.  A statistical framework for in vivo spectroscopic imaging , 1988 .

[31]  C J Hardy,et al.  Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance , 1990, Magnetic resonance in medicine.

[32]  M. Weiner,et al.  Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart. , 1988, Journal of the American College of Cardiology.

[33]  M. Weiner,et al.  Computer simulation of MRS localization techniques: An analysis of ISIS , 1989, Magnetic resonance in medicine.

[34]  W. A. Adams,et al.  In vivo solvent-suppressed localized hydrogen nuclear magnetic resonance spectroscopy: a window to metabolism? , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Okunieff,et al.  Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors. , 1990, The New England journal of medicine.

[36]  M. Weiner,et al.  Noninvasive quantitation of phosphorus metabolites in human tissue by NMR spectroscopy , 1989 .

[37]  C. Hardy,et al.  AIDS dementia complex: brain high-energy phosphate metabolite deficits. , 1990, Radiology.

[38]  R. Herfkens,et al.  Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy. , 1987, Radiology.